• Explore /
  • Poster
  • / Phase II study of trastuzumab with irinotecan in HER2-positive metastatic or advanced gastric cancer patients previously treated with trastuzumab and failed: HGCSG 1201/OGSG1205.

Phase II study of trastuzumab with irinotecan in HER2-positive metastatic or advanced gastric cancer patients previously treated with trastuzumab and failed: HGCSG 1201/OGSG1205.

Abstract Poster

Authors

null

Yasuyuki Kawamoto

Department of Cancer Center, Hokkaido University Hospital, Sapporo, Japan

Yasuyuki Kawamoto , Takashi Meguro , Satoshi Yuki , Hiroshi Nakatsumi , Takahide Sasaki , Kazuteru Hatanaka , Minoru Uebayashi , Ichiro Iwanaga , Nobuhiko Abe , Michio Nakamura , Hiroyuki Okuda , Kazunori Eto , Ayane Oba , Masakazu Abe , Koji Oba , Taroh Satoh , Yuh Sakata , Naoya Sakamoto , Yoshito Komatsu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

UMIN000007636

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 151)

DOI

10.1200/JCO.2017.35.4_suppl.151

Abstract #

151

Poster Bd #

K21

Abstract Disclosures

Similar Posters

First Author: Timothy Jay Price

First Author: Kazuhiro Nishikawa

First Author: Ian Chau

First Author: Ting Han